OpenAlex
PricingAboutJobs
Log inGet started
Work

AMT-130 Huntington’s Disease Gene Therapy: Clinical Study Outcomes at Three Years (PL6.001)

HTML

Year: 2026
Type: conference-abstract
Source: Neurology
DOI: 10.1212/wnl.0000000000216980
Authors: Victor Sung, Grzegorz Witkowski, Erin Furr-Stimming, Ali Samii, Christopher Ross, Bradley Elder, Ralf Reilmann, Jeffrey Long, Vicki Wheelock, Claudia Testa, Samuel Frank, Kenechi Ejebe, Wenfei Zhang, Walid Abi-Saab, David H. Margolin
Institutions: University of Alabama at Birmingham, Wojskowy Instytut Medycyny Lotniczej, The University of Texas Health Science Center at Houston, University of Washington Medical Center, Johns Hopkins University, The Ohio State University, George Huntington Institute, University of Iowa, University of California Davis Medical Center, UC Davis Health, University of California, Davis, University of North Carolina at Chapel Hill, Beth Israel Deaconess Medical Center, Harvard University, UniQure (Netherlands)
Language: English

Topic: Genetic Neurodegenerative Diseases
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: Huntington's disease, gene therapy, total functional capacity, disease progression, dose comparison, adverse events, long-term safety, Enroll-HD, functional decline, neurodegeneration, neuroinflammation, neuroprotection
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W7164201050
Cites:
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms